Status:
WITHDRAWN
EarlySense Monitoring Device Evaluation on CHF Patients
Lead Sponsor:
EarlySense Ltd.
Collaborating Sponsors:
Rambam Health Care Campus
Conditions:
Congestive Heart Failure
Eligibility:
All Genders
45+ years
Brief Summary
CHF patients will be monitored using EarlySense ES-16 device and will simultaneously fill diaries and log their weight daily. The data collected and analyzed by the ES-16 device will be correlated wit...
Eligibility Criteria
Inclusion
- Age over 45 years old
- CHF class II or III with LVEF\<40%
- Hospitalized at least once for CHF deterioration over previous 12 month period
- Able and willing to cooperate with this trial for at least a 3 month period
- Home close to participating center
Exclusion
- Recent (within 3 month) admission to ICU or CC-ICU due to severe CHF episode requiring artificial ventilation
- Asthma or COPD
Key Trial Info
Start Date :
October 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 1 2008
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00382746
Start Date
October 1 2006
End Date
March 1 2008
Last Update
July 19 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Rambam Health Care Campus
Haifa, Israel, 31096